Q4-FY26 · Dr. Satya Narayan Chava
We are a strategic partner for many big pharma right now. So we have a flow of RFP commercial early stage mid-stage late stage commercial.
Laurus Labs · tone and specificity signals across the available quarters.
Language signals
We are a strategic partner for many big pharma right now. So we have a flow of RFP commercial early stage mid-stage late stage commercial.
Most of the capex what we're doing is growth capex. We are not putting capex and hoping customer will come and give projects.
We are very confident on maintaining or improving stable margin in FY27.